IR-825,1558079-49-4,用于腫瘤光熱光動力治療-僅科研
西安凱新生物科技有限公司可以提供一種用于腫瘤癌癥細胞的光熱治療和光動力治療的近紅外熒光染料IR-825，該產品的吸收波長是810nm,發射波長是830nm,該產品的末端帶有羧基COOH活性基團可以參與反應連接其他分子，這個產品的造價要低于ICG-COOH，可以廣泛用于腫瘤的光熱治療。我公司制備的IR-825純度95.4%，可以溶解在二氯甲烷、甲醇、DMF、DMSO里。
供應商：西安凱新生物科技有限公司
電 話 (e)：請點擊展臺進入查看
()：請點擊展臺進入查看
手機（Mobel)：請點擊展臺進入查看
特別說明：該產品僅僅用于科學研究，不用于人體及藥物開發
IR-825 from ruixibio is a near-infrared dye (NIR). IR-825, after encapsulated into nanoparticles may be useful for cancer photothermal and photodynamic therapy. IR-825 nanoparticles showed pH-dependent fluorescence emission and excellent near-infrared (NIR) irradiation of cancer cells targeted in vitro to provide cytotoxicity. IR-825 nanoparticles showed efficient tumor homing together with rapid renal excretion behaviors, as revealed by MR imaging and confirmed by biodistribution measurement. Notably, when irradiated with an 808 nm laser, tumors on mice with IR-825 nanoparticle injection are compley eliminated without recurrence within 60 days, demonstrating the high efficacy of photothermal therapy.
Certificate of Analysis
General properties:
Name：IR825
Molecular Weight：823.4 Dalton
Cat.#：R-H-6012
Lot.#： RM017172
Date of Analysis：2018.01.09
Recommended Retest date：2019.01.09
Stability： 12 months
Storage： -20°C in the dark
Structure
Items | | Specification | Results |
Appearance | | solid | solid |
1H NMR | | Identical to the structure | Identical to the structure |
Foreign Material | | None | None |
Purity by HPLC | | ＞95% | 95.4% |
Report Date: 2018.01.09 | | |
Attachment 1: HPLC
Attachment 2: MS
以上資料源于西安凱新生物科技有限公司
如有其他信息或產品信息咨詢請致電我們
西安凱新生物科技有限公司
電 話 (e)：請點擊展臺進入查看
()：請點擊展臺進入查看
